PMID: 8593934Mar 1, 1996Paper

Increased glutamine:fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM

Diabetes
H Yki-JärvinenD A McClain

Abstract

Overactivity of the hexosamine pathway mediates glucose-induced insulin resistance in rat adipocytes. Glutamine:fructose-6-phosphate amidotransferase (GFA) is the rate-limiting enzyme of this pathway. We determined GFA activity in human skeletal muscle biopsies and rates of insulin-stimulated whole-body, oxidative, and nonoxidative glucose disposal using the euglycemic insulin clamp technique combined with indirect calorimetry (insulin infusion rate (1.5 mU x kg-1 x min-1)) in 12 male patients with NIDDM (age 54 +/- 2 years, BMI 27.5 +/- 0.9 kg/m2, fasting plasma glucose 8.5 +/- 0.6 mmol/l) and 9 matched normal men. GFA activity was detectable in human skeletal muscles and completely inhibited by uridine-5'-diphospho-N-acetylglucosamine (UDP-GlcNAc) in all subjects. GFA activity was 46% increased in the NIDDM patients compared with the normal subjects (9.5 +/- 1.3 vs. 6.5 +/- 1.2 pmol, P < 0.05). Whole-body glucose uptake was 58% decreased in patients with NIDDM (20 +/- 3 micromol x kg body wt-1 x min-1) compared with normal subjects (47 +/- 4 micromol x kg body wt-1 x min-1, P < 0.001). This decrease was attributable to decreases in both glucose oxidation (9 +/- 1 vs. 15 +/- 1 micromol x kg-1 x min-1, NIDDM patients vs. contro...Continue Reading

Citations

Mar 22, 2005·Gene·Satoru IshidaSoichi Takiguchi
Jul 13, 1999·The Journal of Laboratory and Clinical Medicine·W A Oranje, B H Wolffenbuttel
Jun 5, 2002·Biochimica Et Biophysica Acta·Sławomir Milewski
Nov 25, 2000·Journal of Chromatography. B, Biomedical Sciences and Applications·S C BobzinT P Kasten
Sep 10, 2003·Best Practice & Research. Clinical Endocrinology & Metabolism·Juleen R Zierath, Yuichi Kawano
Jul 22, 1999·The New England Journal of Medicine·P R Shepherd, B B Kahn
Aug 16, 2011·The Journal of Biological Chemistry·Michael D DennisLeonard S Jefferson
Jun 8, 2000·Annals of the New York Academy of Sciences·M E Patti
Dec 13, 2005·American Journal of Physiology. Endocrinology and Metabolism·Maria G Buse
Nov 26, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Boglarka LaczyJohn C Chatham
Jan 15, 2013·Molecular Endocrinology·Brent A PenqueJeffrey S Elmendorf
Jan 28, 2016·Aging and Disease·Xiaoting LuoLiang-Jun Yan
May 15, 2010·Trends in Biochemical Sciences·C SlawsonG W Hart
Jun 3, 2004·Diabetes, Obesity & Metabolism·C J Bailey, S L Turner
Mar 13, 2003·Diabetes, Obesity & Metabolism·Sanjay RatnakantSolomon S Solomon
Feb 8, 2005·Biochemical and Biophysical Research Communications·Takuya FujitaIichiro Shimomura
Dec 8, 2004·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Janet E Lindsley, Jared Rutter
Dec 19, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Cheng Xue QinRebecca H Ritchie
Dec 3, 2014·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Tina Tinkara PeterneljJeff S Coombes
May 22, 2020·Circulation Research·Rebecca H Ritchie, E Dale Abel
Oct 7, 2004·Endocrine Reviews·Clara BouchéAllison B Goldfine
Dec 1, 2006·American Journal of Physiology. Cell Physiology·Norbert FülöpJohn C Chatham
Feb 20, 2014·Proteomics. Clinical Applications·Richard D SembaGerald W Hart
Nov 1, 2015·American Journal of Physiology. Heart and Circulatory Physiology·Rudo F Mapanga, M Faadiel Essop
Jun 6, 2017·Endocrinology·Sarah E Hugo, Amnon Schlegel
Aug 25, 2020·Oxidative Medicine and Cellular Longevity·Lei PangXin Yu
Feb 26, 2010·Journal of Muscle Research and Cell Motility·C Cieniewski-BernardB Bastide

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.